One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?

BACKGROUND: Ataluren was approved for the treatment of nmDMD, both the efficacy and safety have been previously reported only from clinical trials but no report exists about real-life experience. PATIENT/METHODS: we describe three Italian children with nmDMD treated with ataluren for 1 year. Measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, Lucia, Iodice, Rosa, Esposito, Marcello, Dubbioso, Raffaele, Tozza, Stefano, Vitale, Floriana, Santoro, Lucio, Manganelli, Fiore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236582/
https://www.ncbi.nlm.nih.gov/pubmed/30542376
http://dx.doi.org/10.1177/1756286418809588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236582/
https://www.ncbi.nlm.nih.gov/pubmed/30542376
http://dx.doi.org/10.1177/1756286418809588

Ejemplares similares